Asked by: Julian Smith (Conservative - Skipton and Ripon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what mechanisms are in place for NHS mental health trusts to be held accountable when written recommendations for improving carer involvement and crisis support following formal apologies are not implemented within agreed timescales.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Anyone receiving treatment for their mental health deserves safe, high-quality care, and to be treated with dignity and respect.
Families, staff, and the public deserve answers when things go wrong in mental health settings and it is vitally important that, where care falls short, we learn from any mistakes made to improve care across the National Health Service and protect patients in the future.
All NHS providers are held to account under the NHS Oversight Framework 2025/26 when they fail to implement written recommendations, for instance on carer involvement or crisis support, in agreed timescales. This includes a capability assessment, where trusts are evaluated for leadership, governance, and ability to implement change, with failures heightening oversight. As part of the Provider Improvement Programme, low performing trusts enter a structured programme, gaining intensive, formal improvement interventions.
NHS England can formally step in using its enforcement guidance if performance or governance is below acceptable standards. NHS England regional teams convene regular meetings with trusts and integrated care boards to review progress on agreed recommendations and implementation plans.
It is the role of the Parliamentary and Health Service Ombudsman to carry out independent investigations into complaints about treatment or service provided through the NHS where organisation level complaints processes have already been followed.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has assessed whether NICE has approved a greater or fewer number of new medicines since the introduction of the severity modifier in 2020, compared with comparable international health systems.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended to make NICE’s methods fairer, faster and more consistent.
NICE carried out a review of the implementation of the severity modifier in September 2024 and found that it is operating as intended with a greater proportion of medicines recommended than under NICE’s previous methods. Since then, NICE has continued to monitor how the severity modifier is being applied. The latest figures include data from technology appraisals published up until the end of September 2025 and show that the proportion of positive decisions has increased since the severity modifier was implemented and since data was published in September 2024. 87.0% of decisions taken since the severity modifier was implemented, compared with 82.5% when the end-of-life modifier was being used. NICE is also recommending a greater proportion of new cancer treatments overall, 86.3% compared to 75.0%, and advanced cancer treatments specifically, 84.8% compared to 69.1%.
NICE has commissioned research to gather further evidence on societal preferences that will inform future methods reviews.
Asked by: Julian Smith (Conservative - Skipton and Ripon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of ensuring that NHS mental health trusts do not discharge patients with high PHQ-9 and GAD-7 scores without robust safety planning and follow-up support; and what guidance his Department has issued to help prevent such cases.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
In 2024, statutory guidance was issued on discharge from all mental health, and learning disability and autism inpatient settings, under the NHS Act 2006. The guidance also sets out that prior to discharge, robust planning and safety management should be developed for all patients, in collaboration with the person and their chosen carer or carers with input from relevant members of the multi-disciplinary team.
For individuals detained under the Mental Health Act, in the Mental Health Act 2025, passed this year, we have strengthened discharge decision making by requiring consultation with another professional before discharge, as well as introducing requirements around care and treatment planning. We will provide further guidance on this in the revised Code of Practice.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to provide financial support to redress schemes relating to pelvic mesh and valproate proposed by devolved governments.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report. To progress this, I met with the patient safety commissioner late last year and we continue to work closely together.
Should a decision be made for any United Kingdom-wide scheme, appropriate steps would also be taken to engage across the UK at the earliest opportunity. I am also in contact with ministers within the devolved administrations, with engagement between officials across the UK occurring regularly.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his department has considered the impact of NICE’s severity modifier, introduced in 2020, on NHS England’s access to innovative cancer medicines which were previously eligible under the end-of-life weighting.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended to make NICE’s methods fairer, faster and more consistent.
NICE carried out a review of the implementation of the severity modifier in September 2024 and found that it is operating as intended with a greater proportion of medicines recommended than under NICE’s previous methods. Since then, NICE has continued to monitor how the severity modifier is being applied. The latest figures include data from technology appraisals published up until the end of September 2025 and show that the proportion of positive decisions has increased since the severity modifier was implemented and since data was published in September 2024. 87.0% of decisions taken since the severity modifier was implemented, compared with 82.5% when the end-of-life modifier was being used. NICE is also recommending a greater proportion of new cancer treatments overall, 86.3% compared to 75.0%, and advanced cancer treatments specifically, 84.8% compared to 69.1%.
NICE has commissioned research to gather further evidence on societal preferences that will inform future methods reviews.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department made an impact assessment of the effect of NICE’s severity modifier, introduced in 2020, on the ability of cancer medicines to meet the new ‘high severity’ threshold for approval.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended to make NICE’s methods fairer, faster and more consistent.
NICE carried out a review of the implementation of the severity modifier in September 2024 and found that it is operating as intended with a greater proportion of medicines recommended than under NICE’s previous methods. Since then, NICE has continued to monitor how the severity modifier is being applied. The latest figures include data from technology appraisals published up until the end of September 2025 and show that the proportion of positive decisions has increased since the severity modifier was implemented and since data was published in September 2024. 87.0% of decisions taken since the severity modifier was implemented, compared with 82.5% when the end-of-life modifier was being used. NICE is also recommending a greater proportion of new cancer treatments overall, 86.3% compared to 75.0%, and advanced cancer treatments specifically, 84.8% compared to 69.1%.
NICE has commissioned research to gather further evidence on societal preferences that will inform future methods reviews.
Asked by: Nadia Whittome (Labour - Nottingham East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of partial retirement for NHS staff on redundancy entitlements; and what discussions his Department has had with NHS representatives on ensuring staff were informed of the employment and redundancy implications of partial retirement.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Partial retirement does not mean that National Health Service staff are ineligible for redundancy payments. However, taking partial retirement may change the way in which contractual redundancy payments are calculated.
The rules concerning the calculation of redundancy payments for NHS staff who have previously taken pension benefits, are determined in accordance with their contracts of employment, and statutory redundancy entitlements.
Redundancy terms for NHS staff on the Agenda for Change contract are set out under section 16 of the NHS Staff Terms and Conditions of Service handbook. This also applies to NHS staff whose redundancy terms refer to section 16. This section states that service used for the purposes of calculating previous pension benefits will not count for the calculation of a contractual redundancy payment. Statutory redundancy entitlements are unaffected.
The Department commissions NHS Employers to provide guidance for employers on a range of topics, including NHS redundancy arrangements and retirement options for NHS staff.
Asked by: Nadia Whittome (Labour - Nottingham East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage trainee doctors to take up rehabilitation as a specialism.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We are committed to training the staff we need, including rehabilitation specialists, to ensure patients are cared for by the right professional, when and where they need it.
As of September 2025, there are 490 full-time equivalent (FTE) doctors working in the speciality of rehabilitation medicine in National Health Service trusts and other core organisations in England. This is 24, or 5%, more than last year, 116, or 31.2%, more than 2020, and 232, or 90.2%, more than in 2010. This includes over 164 FTE consultants. This is seven, or 4.3%, more than last year, 15, or 10%, more than in 2020, and 50, or 43.8%, more than in 2010.
Fill rates for ST3 level rehabilitation medicine have been increasing. 94% of training posts were filled in 2025 compared to 54% in 2023 and 60% in 2024.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the decision to prioritise continuation funding for the existing 75 Start for Life local authority areas aligns with the commitment in the 10-Year Health Plan for England to expand Start for Life services across all communities.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of hospice funding for dementia end-of-life care is provided by central government and local authorities; and whether he plans to increase statutory funding for hospices.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.